查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585658

生物製药製造消耗品测试市场：按产品类型、类型、应用划分 - 全球预测 2025-2030

Biopharmaceuticals Manufacturing Consumables Testing Market by Product Type (Consumables, Instruments, Services), Type (Compendial Testing, Custom Testing, Laboratory Testing), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年生物製药製造耗材测试市场规模为5,5875万美元，预计2024年将达6,2,139万美元，复合年增长率为11.71%，2030年将达12亿美元，预计将达到1,354万美元。

生物製药製造耗材测试市场涵盖确保生物製药製造过程中使用的耗材的安全性、有效性和合规性所需的分析过程和材料。这些耗材包括培养基、试剂、过滤设备和其他直接影响药品的关键零件，因此受到严格的品质保证。对消耗品测试的需求源于对生技药品不断增长的需求、日益严格的监管环境（需要严格的安全检查）以及生物製药製造技术的不断创新。此类测试的应用范围广泛，包括细胞培养测试、生物加工、污染监测和品管，主要在製药公司、实验室和受託製造厂商。一次性技术的日益采用、生物技术投资的增加以及生技药品和生物仿製药的不断涌现推动了市场成长。然而，其局限性包括测试耗材的高成本、生技药品製造的复杂性以及严格的监管合规要求。关键的成长机会在于自动化技术的进步，以简化检查流程，以及整合人工智慧进行预测分析，提高准确性和效率。永续实践和环保测试耗材的引入进一步为降低成本和提高环境合规性提供了有利途径。公司可以透过投资强有力的研发来创新新的测试方法和材料来缓解挑战。竞争格局仍然充满活力，在即时检测技术、提高灵敏度的检测以及专为利基治疗领域设计的客製化耗材方面具有巨大的创新潜力。企业必须优先考虑灵活应对监管变化，并与高科技公司建立合作伙伴关係，以利用数位技术的进步，从而应对这个不断发展的市场的复杂性。随着业界朝向精准医疗迈进，开发针对个人化医疗方案的耗材的针对性研究可以提供决定性的竞争优势。

主要市场统计
基准年[2023] 55875万美元
预测年份 [2024] 62139万美元
预测年份 [2030] 1,213.54 百万美元
复合年增长率（%） 11.71%

市场动态：针对快速发展的生物製药製造消耗品测试市场揭示的关键市场洞察

生物製药製造耗材测试市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 生物製药需求增加
    • 生物製药耗材品质保证和安全的严格监管要求
  • 市场限制因素
    • 引进测试设备的高成本
  • 市场机会
    • 高效率生物製药耗材检测技术的进展
    • 各国生物製药产业的扩张
  • 市场挑战
    • 响应每个地区不断变化的法规和标准

波特五力：引领生物製药製造消耗品测试市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解生物製药製造耗材测试市场的外部影响

外部宏观环境因素在塑造生物製药製造消耗品测试市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解生物製药製造耗材测试市场的竞争状况

生物製药製造消耗品测试市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵生物製药製造耗材测试市场供应商绩效评估

FPNV定位矩阵是评估生物製药製造耗材测试市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划生物製药製造消耗品测试市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对生物製药製造消耗品测试市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 生物製药需求增加
      • 生物製药耗材品质保证和安全的严格监管要求
    • 抑制因素
      • 引进测试设备的高成本
    • 机会
      • 生物製药耗材高效率检测的技术进步
      • 生物製药产业在整个经济中持续扩张。
    • 任务
      • 适应不同地区不断变化的法规和标准
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章生物製药製造耗材测试市场：依产品类型

  • 消耗品
  • 装置
  • 服务

第七章生物製药製造耗材测试市场：按类型

  • 药典测试
  • 自订测试
  • 临床检查
    • 化学分析测试
    • 酵素测试
    • 稳定性测试
    • 无菌测试

第八章生物製药製造耗材测试市场：依应用分类

  • 生物製药製造
  • 品管与保证
  • 研究与开发

第九章 北美、南美洲生物製药製造耗材检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太生物製药製造耗材检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲/中东/非洲生物製药製造耗材检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Agilent Technologies, Inc.
  • Alcami Corporation
  • Almac Group Limited
  • ALS Limited
  • ASTM International
  • Avance Biosciences, Inc.
  • Becton, Dickinson and Company
  • BioConvergence LLC
  • BioLife Solutions Inc.
  • bioMerieux SA
  • Boston Analytical, Inc.
  • Bureau Veritas SA
  • Catalent, Inc
  • Charles River Laboratories International, Inc.
  • Curia Global, Inc.
  • DEKRA SE
  • EM Topco Limited
  • Eurofins Scientific SE
  • Intertek Group PLC
  • Laboratory Corporation of America
  • LGM Pharma, LLC
  • Life Technologies（India）Pvt Ltd.
  • Merck KGaA
  • MISTRAS Group, Inc.
  • Neopharm Labs Inc.
  • Ortho-Clinical Diagnostics, Inc.
  • Pace Analytical Services, LLC
  • Pacific BioLabs, Inc.
  • ProtaGene, GmbH.
  • Sartorius AG
  • SGS SA
  • Sotera Health Company
  • STERIS PLC
  • Tentamus Group GmbH
  • Thermo Fisher Scientific Inc.
  • TUV SUD ELAB GmbH
  • WuXi AppTec, Inc.
Product Code: MRR-521BAA36EA7E

The Biopharmaceuticals Manufacturing Consumables Testing Market was valued at USD 558.75 million in 2023, expected to reach USD 621.39 million in 2024, and is projected to grow at a CAGR of 11.71%, to USD 1,213.54 million by 2030.

The biopharmaceuticals manufacturing consumables testing market encapsulates the analytical processes and materials required to ensure the safety, efficacy, and compliance of consumables used during the production of biologic drugs. These consumables include culture media, reagents, filtration devices, and other critical components that warrant stringent quality assurance due to their direct impact on drug products. The necessity of consumables testing arises from the growing demand for biologics, tighter regulatory landscapes demanding rigorous safety checks, and the continuous innovation in biopharmaceutical production techniques. The application of such testing is vast, encompassing cell culture testing, bioprocessing, contamination monitoring, and quality control, mainly in pharmaceutical companies, research laboratories, and contract manufacturing organizations. The market growth is bolstered by the increasing adoption of single-use technologies, rising biotech investments, and a burgeoning pipeline of biologics and biosimilars. However, some of the prevailing limitations include the high cost of consumables testing, the complexity involved in biologics manufacturing, and stringent regulatory compliance requirements. Key growth opportunities lie in the advancement of automation technologies, which streamline testing processes, and the integration of artificial intelligence for predictive analytics, enhancing accuracy and efficiency. Implementing sustainable practices and environmentally-friendly testing consumables further presents lucrative avenues for reducing costs and improving eco-compliance. Companies can mitigate challenges by investing in robust R&D to innovate new testing methodologies and materials. The competitive landscape remains dynamic, with significant innovation potential in real-time testing technologies, enhanced sensitivity assays, and customized consumables designed for niche therapeutic areas. Businesses must prioritize agile adaptation to regulatory changes and foster collaborations with tech firms to capitalize on digital advancements, thereby steering through the complexities of this evolving market. As the industry leans towards precision medicine, targeted research into developing consumables that cater specifically to personalized medicine protocols could offer a decisive competitive edge.

KEY MARKET STATISTICS
Base Year [2023] USD 558.75 million
Estimated Year [2024] USD 621.39 million
Forecast Year [2030] USD 1,213.54 million
CAGR (%) 11.71%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biopharmaceuticals Manufacturing Consumables Testing Market

The Biopharmaceuticals Manufacturing Consumables Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing demand for biopharmaceutical products
    • Stringent regulatory requirements for quality assurance and safety of biopharmaceutical consumables
  • Market Restraints
    • High costs associated with deployment of testing equipment
  • Market Opportunities
    • Advancements in technologies for efficient biopharmaceutical consumables testing
    • Growing expansion of biopharmaceutical industry across economies
  • Market Challenges
    • Adapting to evolving regulations and standards across regions

Porter's Five Forces: A Strategic Tool for Navigating the Biopharmaceuticals Manufacturing Consumables Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biopharmaceuticals Manufacturing Consumables Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biopharmaceuticals Manufacturing Consumables Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biopharmaceuticals Manufacturing Consumables Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biopharmaceuticals Manufacturing Consumables Testing Market

A detailed market share analysis in the Biopharmaceuticals Manufacturing Consumables Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biopharmaceuticals Manufacturing Consumables Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biopharmaceuticals Manufacturing Consumables Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biopharmaceuticals Manufacturing Consumables Testing Market

A strategic analysis of the Biopharmaceuticals Manufacturing Consumables Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biopharmaceuticals Manufacturing Consumables Testing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Alcami Corporation, Almac Group Limited, ALS Limited, ASTM International, Avance Biosciences, Inc., Becton, Dickinson and Company, BioConvergence LLC, BioLife Solutions Inc., bioMerieux SA, Boston Analytical, Inc., Bureau Veritas SA, Catalent, Inc, Charles River Laboratories International, Inc., Curia Global, Inc., DEKRA SE, EM Topco Limited, Eurofins Scientific SE, Intertek Group PLC, Laboratory Corporation of America, LGM Pharma, LLC, Life Technologies (India) Pvt Ltd., Merck KGaA, MISTRAS Group, Inc., Neopharm Labs Inc., Ortho-Clinical Diagnostics, Inc., Pace Analytical Services, LLC, Pacific BioLabs, Inc., ProtaGene, GmbH., Sartorius AG, SGS SA, Sotera Health Company, STERIS PLC, Tentamus Group GmbH, Thermo Fisher Scientific Inc., TUV SUD ELAB GmbH, and WuXi AppTec, Inc..

Market Segmentation & Coverage

This research report categorizes the Biopharmaceuticals Manufacturing Consumables Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Consumables, Instruments, and Services.
  • Based on Type, market is studied across Compendial Testing, Custom Testing, and Laboratory Testing. The Laboratory Testing is further studied across Chemical Analysis Testing, Enzyme Testing, Stability Testing, and Sterility Testing.
  • Based on Application, market is studied across Biopharmaceuticals Production, Quality Control & Assurance, and Research & Development.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for biopharmaceutical products
      • 5.1.1.2. Stringent regulatory requirements for quality assurance and safety of biopharmaceutical consumables
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with deployment of testing equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in technologies for efficient biopharmaceutical consumables testing
      • 5.1.3.2. Growing expansion of biopharmaceutical industry across economies
    • 5.1.4. Challenges
      • 5.1.4.1. Adapting to evolving regulations and standards across regions
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biopharmaceuticals Manufacturing Consumables Testing Market, by Product Type

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments
  • 6.4. Services

7. Biopharmaceuticals Manufacturing Consumables Testing Market, by Type

  • 7.1. Introduction
  • 7.2. Compendial Testing
  • 7.3. Custom Testing
  • 7.4. Laboratory Testing
    • 7.4.1. Chemical Analysis Testing
    • 7.4.2. Enzyme Testing
    • 7.4.3. Stability Testing
    • 7.4.4. Sterility Testing

8. Biopharmaceuticals Manufacturing Consumables Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Biopharmaceuticals Production
  • 8.3. Quality Control & Assurance
  • 8.4. Research & Development

9. Americas Biopharmaceuticals Manufacturing Consumables Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Biopharmaceuticals Manufacturing Consumables Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Biopharmaceuticals Manufacturing Consumables Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Alcami Corporation
  • 3. Almac Group Limited
  • 4. ALS Limited
  • 5. ASTM International
  • 6. Avance Biosciences, Inc.
  • 7. Becton, Dickinson and Company
  • 8. BioConvergence LLC
  • 9. BioLife Solutions Inc.
  • 10. bioMerieux SA
  • 11. Boston Analytical, Inc.
  • 12. Bureau Veritas SA
  • 13. Catalent, Inc
  • 14. Charles River Laboratories International, Inc.
  • 15. Curia Global, Inc.
  • 16. DEKRA SE
  • 17. EM Topco Limited
  • 18. Eurofins Scientific SE
  • 19. Intertek Group PLC
  • 20. Laboratory Corporation of America
  • 21. LGM Pharma, LLC
  • 22. Life Technologies (India) Pvt Ltd.
  • 23. Merck KGaA
  • 24. MISTRAS Group, Inc.
  • 25. Neopharm Labs Inc.
  • 26. Ortho-Clinical Diagnostics, Inc.
  • 27. Pace Analytical Services, LLC
  • 28. Pacific BioLabs, Inc.
  • 29. ProtaGene, GmbH.
  • 30. Sartorius AG
  • 31. SGS SA
  • 32. Sotera Health Company
  • 33. STERIS PLC
  • 34. Tentamus Group GmbH
  • 35. Thermo Fisher Scientific Inc.
  • 36. TUV SUD ELAB GmbH
  • 37. WuXi AppTec, Inc.

LIST OF FIGURES

  • FIGURE 1. BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COMPENDIAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CUSTOM TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CHEMICAL ANALYSIS TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY ENZYME TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STABILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STERILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY BIOPHARMACEUTICALS PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY QUALITY CONTROL & ASSURANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET, FPNV POSITIONING MATRIX, 2023